The network is called Green Bridge Gateway and aims to help companies overcome hurdles of entering the UK and EU cannabinoid markets.
The Association for the Cannabinoid Industry (ACI; London) has launched a new network called Green Bridge Gateway that offers services from providers with cannabinoids expertise. These companies offer to support companies outside of the UK and the EU that need guidance in entering either of these markets.
The Green Bridge Gateway network now includes four companies: Global Regulatory Services, ADSL, Shweed, and Chem ID. Together, they provide help with new product development, analytical testing, toxicology testing, chemical data management, supply chain management, and business development strategy.
The network targets industries including medical, food and drink, and cosmetics. “Green Bridge Gateway provides a unique range of services which will enable legal cannabis companies across the globe to secure market entry to the UK and EU,” stated ACI’s co-founder Steve Moor, in a press release. “This unique partnership will provide expert guidance to help any business with ambitions to expand into one or both territories, with the confidence that every regulatory requirement will be met.”
Mark Bowes Cavanagh, CEO of ADSL, added, “We have been working closely with ACI for the past four years, being very successful in novel food applications. We are very excited to be part of the Green Bridge Gateway ecosystem, helping customers navigate the complex CBD world, changing regulations, data review, and testing requirements. We guide our clients every step of the way.”
Kaneka Nutrients to unveil new consumer research on menopausal women at Vitafoods Europe 2024
April 26th 2024The company will reveal the results of the research that is based on live feedback from 200 menopausal women who took 200 mg per day of Kaneka Ubiquinol over two-months, monitored the effects, and recorded their observations.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.